Literature DB >> 2784477

T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP.

H S de Koster1, D C Anderson, A Termijtelen.   

Abstract

T cell clones raised against a synthetic peptide, identical to the third hypervariable region of the DR3 BI chain, were tested for secondary proliferative responses against a panel of PBLs. All seven DR3 DPw3+ stimulators could induce proliferation. DR3- DPw3+ PBLs were recognized when the synthetic peptide was added to the cultures. Inhibition studies with mAbs showed that in both cases the HLA-DP molecule is involved in the recognition of both types of stimulators. We conclude that the clones recognize the DR3 peptide presented by HLA-DPw3. This stimulus can be obtained in two different ways: (a) by addition of synthetic peptide to DPw3+ PBLs or (b) by using DR3 DPw3+ stimulator cells where DR3 peptides are present in the culture as a product of denaturation of the DR3 molecule. Because all DR3 DPw3+ PBLs tested could stimulate the line and clones, we assume that the presentation of the DR3 peptide by DP is a naturally and continuously occurring phenomenon.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784477      PMCID: PMC2189256          DOI: 10.1084/jem.169.3.1191

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

Review 2.  Antigen-presenting function of the macrophage.

Authors:  E R Unanue
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

3.  Exact definition of species-specific and cross-reactive epitopes of the 65-kilodalton protein of Mycobacterium leprae using synthetic peptides.

Authors:  D C Anderson; M E Barry; T M Buchanan
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

4.  Immunology. The ins and outs of antigen processing and presentation.

Authors:  R N Germain
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

5.  HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.

Authors:  C Clayberger; P Parham; J Rothbard; D S Ludwig; G K Schoolnik; A M Krensky
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

6.  Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.

Authors:  N Rebai; B Malissen; M Pierres; R S Accolla; G Corte; C Mawas
Journal:  Eur J Immunol       Date:  1983-02       Impact factor: 5.532

7.  Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life.

Authors:  F H Claas; Y Gijbels; J van der Velden-de Munck; J J van Rood
Journal:  Science       Date:  1988-09-30       Impact factor: 47.728

8.  Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes.

Authors:  K Ziegler; E R Unanue
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

9.  A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide.

Authors:  D C Anderson; W C van Schooten; M E Barry; A A Janson; T M Buchanan; R R de Vries
Journal:  Science       Date:  1988-10-14       Impact factor: 47.728

10.  Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA.

Authors:  J L Maryanski; P Pala; J C Cerottini; G Corradin
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  21 in total

1.  Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization.

Authors:  J M Tiercy; C Morel; A C Freidel; F Zwahlen; L Gebuhrer; H Bétuel; M Jeannet; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  An aberrant DRB4 null gene transcript is found that could encode a novel HLA-DR beta chain.

Authors:  V R Sutton; R W Knowles
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 3.  Self determinant selection and acquisition of the autoimmune T cell repertoire.

Authors:  G Benichou; R C Tam; P I Orr; M R Garovoy; E V Fedoseyeva
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

4.  HLA-DP and coeliac disease: family and population studies.

Authors:  C Caffrey; G A Hitman; M J Niven; P G Cassell; P Kumar; L Fry; P Mackintosh; R Gallagher; C Feighery; D Weir
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

5.  Evidence for cobinding of self- and allopeptides to human class II major histocompatibility antigen DR1 by energy transfer.

Authors:  H Kropshofer; H Max; H Kalbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

6.  HLA class I/class II interaction in early onset pauciarticular juvenile chronic arthritis.

Authors:  C Paul; J P Haas; U Schoenwald; H Truckenbrodt; M P Bettinotti; J Bönisch; G Brünnler; E Keller; C Nevinny-Stickel; Z Yao
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Authors:  J Joseph Melenhorst; Phillip Scheinberg; Ann Williams; David R Ambrozak; Keyvan Keyvanfar; Melody Smith; J Philip McCoy; Nancy F Hensel; Daniel C Douek; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

8.  A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution.

Authors:  R H Scofield; W L Warren; G Koelsch; J B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

9.  On the nature of peptides involved in T cell alloreactivity.

Authors:  O Rötzschke; K Falk; S Faath; H G Rammensee
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

10.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.